Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain DOI
Roxana Geoffrion, Emily C. Yang, Nicole Koenig

et al.

Obstetrics and Gynecology, Journal Year: 2020, Volume and Issue: 137(1), P. 91 - 99

Published: Dec. 1, 2020

OBJECTIVE: To evaluate the prevalence and characteristics of recreational cannabis use in women with pelvic pain, to examine influence legalization on these parameters. METHODS: We conducted a retrospective analysis prospective registry self-reported moderate-to-severe pain referred tertiary care clinic Vancouver, Canada, 2013–2019. excluded patients aged 18 years or younger those unknown data use. Demographic, clinical, validated questionnaire were extracted for two main analyses: 1) comparison current users nonusers, 2) who entered before (October 17, 2018) after legalization. RESULTS: Overall, 14.9% (509/3,426) classified as users. Compared ( P <.001), had lower levels education <.001) household income taking opioids antiinflammatories =.003), neuromodulators =.020), herbal medications more frequently. They worse scores depression, anxiety, catastrophizing, quality life, severity <.001 all). After legalization, increased from 13.3% (366/2,760) 21.5% (143/666) <.001). prelegalization, postlegalization associated higher anxiety =.036), catastrophizing scores. fewer neuroleptics =.027) daily narcotics =.026), but =.010). CONCLUSION: Recreational among Canada. Cannabis pain-related morbidities. Postlegalization, less likely require compared The role, perceived benefits, possible risks further investigation. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02911090.

Language: Английский

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update DOI Creative Commons
Benedikt Fischer, Tessa Robinson, Chris Bullen

et al.

International Journal of Drug Policy, Journal Year: 2021, Volume and Issue: 99, P. 103381 - 103381

Published: Aug. 28, 2021

Cannabis use is common, especially among young people, and associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public goals. Evidence-based 'Lower Risk Use Guidelines' (LRCUG) recommendations were previously developed reduce modifiable risk factors of cannabis-related adverse outcomes; related evidence has evolved substantially since. We aimed review new scientific develop comprehensively up-to-date LRCUG, including their recommendations, on this basis. Targeted searches literature (since 2016) main outcomes by the user-individual conducted. Topical areas informed previous LRCUG content expanded upon current evidence. Searches preferentially focused systematic reviews, supplemented key individual studies. The results evidence-graded, topically organized narratively summarized; through an iterative expert consensus development process. A substantial body cannabis use-related harms identified varying quality. Twelve substantive recommendation clusters three precautionary statements developed. In general, suggests that individuals can if they delay onset until after adolescence, avoid high-potency (THC) products high-frequency/-intensity use, refrain from smoking-routes administration. While people are particularly vulnerable harms, other sub-groups (e.g., pregnant women, drivers, older adults, those co-morbidities) advised exercise particular caution risks. Legal/regulated should be used where possible. result in outcomes, mostly higher-risk use. Reducing help offer one targeted intervention component within a comprehensive approach They require effective audience-tailoring dissemination, regular updating as become available, evaluated impact.

Language: Английский

Citations

137

Endocannabinoids, cannabinoids and the regulation of anxiety DOI
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema

et al.

Neuropharmacology, Journal Year: 2021, Volume and Issue: 195, P. 108626 - 108626

Published: June 8, 2021

Language: Английский

Citations

59

The why behind the high: determinants of neurocognition during acute cannabis exposure DOI
Johannes G. Ramaekers, Natasha L. Mason, Lilian Kloft

et al.

Nature reviews. Neuroscience, Journal Year: 2021, Volume and Issue: 22(7), P. 439 - 454

Published: May 27, 2021

Language: Английский

Citations

55

Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring DOI

Gregory Rompala,

Yoko Nomura, Yasmin L. Hurd

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2021, Volume and Issue: 118(47)

Published: Nov. 15, 2021

Significance Cannabis use is becoming more prevalent, including during developmentally sensitive periods such as pregnancy. Here we find that maternal cannabis associated with increased cortisol, anxiety, aggression, and hyperactivity in young children. This corresponded widespread reductions immune-related gene expression the placenta which correlated anxiety hyperactivity. Future studies are needed to examine effects of on immune function pregnancy a potential regulatory mechanism shaping neurobehavioral development.

Language: Английский

Citations

49

Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence DOI
Lauren Kuhns, Emese Kroon, Karis Colyer‐Patel

et al.

Psychopharmacology, Journal Year: 2021, Volume and Issue: 239(5), P. 1231 - 1249

Published: Nov. 6, 2021

Language: Английский

Citations

44

The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study DOI Creative Commons
Weiqiu Cheng, Nadine Parker, Naz Karadag

et al.

The Lancet Psychiatry, Journal Year: 2023, Volume and Issue: 10(6), P. 441 - 451

Published: May 17, 2023

Language: Английский

Citations

20

Presynaptic nanoscale components of retrograde synaptic signaling DOI Creative Commons
Benjámin Barti, Barna Dudok, Kata Kenesei

et al.

Science Advances, Journal Year: 2024, Volume and Issue: 10(22)

Published: May 29, 2024

While our understanding of the nanoscale architecture anterograde synaptic transmission is rapidly expanding, qualitative and quantitative molecular principles underlying distinct mechanisms retrograde communication remain elusive. We show that a particular form tonic cannabinoid signaling essential for setting target cell-dependent variability. It does not require activity two major endocannabinoid-producing enzymes. Instead, by developing workflow physiological, anatomical, measurements at same unitary synapse, we demonstrate stoichiometric ratio type 1 receptors (CB

Language: Английский

Citations

7

Multiple clinical risks for cannabis users during the COVID-19 pandemic DOI Creative Commons

Ellen Mello Borgonhi,

Vanessa Loss Volpatto,

Felipe Ornell

et al.

Addiction Science & Clinical Practice, Journal Year: 2021, Volume and Issue: 16(1)

Published: Jan. 20, 2021

The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. identification of risk groups is essential the establishment preventive therapeutic strategies, as substance users. During COVID-19 pandemic, there was an increase in use psychoactive substances during lockdown, including cannabis. This commentary reviews relevant findings discusses scientific evidence on risks worse clinical psychiatric complications due to coronavirus disease subjects who Although they are not included group recommendations that disease, may have more vulnerable respiratory system viral diseases. There certain similarities between harmful cardiovascular effects cannabis those smoking. Due different modes smoking, chemicals retained body longe also contain other toxic such tar, found tobacco which associated with development lung cancer, bronchitis pulmonary emphysema. Therefore, we discuss if individuals regularly might be infection. population deserves attention worldwide this manuscript can help clinicians become aware pandemics develop specific intervention strategies.

Language: Английский

Citations

33

Author response: A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use DOI Open Access
Yihe Weng,

Johann Kruschwitz,

Laura M. Rueda‐Delgado

et al.

Published: July 18, 2024

Substance use, including cigarettes and cannabis, is associated with poorer sustained attention in late adolescence early adulthood. Previous studies were predominantly cross-sectional or under-powered could not indicate if impairment was a predictor of substance-use marker the inclination to engage such behaviour. This study explored relationship between substance use across longitudinal span from ages 14 23 over 1,000 participants. Behaviours brain connectivity diminished at age predicted subsequent increases cannabis cigarette smoking, establishing as robust biomarker for vulnerability use. Individual differences network strength relevant preserved developmental stages networks generalized participants an external dataset. In summary, are robust, consistent, able predict aspects later use.A predicts 23.

Language: Английский

Citations

5

The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial DOI
Xiaomin Xu,

Xinni Ding,

Liyu Chen

et al.

Journal of Psychiatric Research, Journal Year: 2020, Volume and Issue: 134, P. 102 - 110

Published: Dec. 22, 2020

Language: Английский

Citations

28